Comfort, restored — locally and gently.
Yes — low-dose vaginal estrogen is the most effective treatment for GSM, and unlike hot flashes, these symptoms rarely improve without treatment. The genitourinary syndrome of menopause (GSM) affects up to half of postmenopausal women. Low-dose vaginal estradiol restores tissue thickness, elasticity, and moisture directly at the source, with only minimal hormone reaching the bloodstream.
Medically reviewed by Sean Arora, MD. Educational, not a substitute for medical advice.
Options for this symptom
Transparent pricing — the cost is the medication, with free shipping and clinician messaging included.
Estradiol vaginal cream
Vaginal cream · Prescription
$99/mo
billed monthly
Local estrogen for vaginal and urinary symptoms.
No membership fee. The price is the medication — free shipping and clinician messaging included. See full pricing
What this looks like
- Vaginal dryness and irritation
- Painful or uncomfortable intimacy
- Urinary urgency or recurrent UTIs
- Burning or itching
Evidence-led, clinician-reviewed care
We start with the treatments the guidelines support and tailor them to you.
Low-dose vaginal estradiol
Low-dose local estrogen rebuilds tissue with minimal systemic absorption.
A simple maintenance routine
A short initial course, then twice-weekly maintenance — adjusted by your clinician to keep symptoms away.
What the guidelines say.
Our recommendations follow The Menopause Society and ACOG. Every therapy carries benefits and risks, and a licensed clinician reviews whether it is appropriate for you.
The Menopause Society, GSM Position Statement
Low-dose vaginal estrogen is effective for GSM with minimal systemic absorption.
The Menopause Society, GSM Position Statement
The genitourinary syndrome of menopause affects up to half of postmenopausal women and, unlike vasomotor symptoms, tends to persist or worsen over time without treatment.
The Menopause Society, GSM Position Statement
The genitourinary syndrome of menopause, driven by estrogen decline, is associated with recurrent urinary tract infections, and low-dose vaginal estrogen can reduce their recurrence in postmenopausal women.
Questions, answered
Often, yes. Low-dose vaginal therapy acts locally on vaginal and urinary tissue with only minimal systemic absorption, which is a different risk conversation from systemic hormone therapy like patches or pills. Your clinician still reviews your full health history during your visit to confirm it's a safe fit for you.
Feel like yourself again.
Take the 3-minute assessment, then meet your clinician by video or phone. No obligation.